2024/11/08 19:31:07 | |
---|---|
Price | |
61.89 EUR | |
Difference | 2.08% (1.26) |
ISIN | US28176E1082 |
Symbol | EW |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 36,737 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 60.78 EUR |
High | 61.89 EUR |
Low | 60.69 EUR |
Close (prev. day) | 60.63 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/11/05 | Global Equity Ratings | ||
2024/10/29 | Global Equity Ratings | ||
2024/10/22 | Global Equity Ratings | ||
2024/10/08 | Global Strategy 4Q 2024 | ||
2024/09/27 | Global Equity Ratings |
2024/11/08 19:31:07 | |
---|---|
Price | |
61.89 EUR | |
Difference | 2.08% (1.26) |
ISIN | US28176E1082 |
Symbol | EW |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 36,737 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 60.78 EUR |
High | 61.89 EUR |
Low | 60.69 EUR |
Close (prev. day) | 60.63 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -23.66% | -2.30% | -40.65% |
Perf (abs.) | -18.79 | -1.43 | -41.52 |
Beta | 0.85 | 0.85 | 0.98 |
Volatility | 53.55 | 42.76 | 36.60 |
Ø price 5 days | Ø volume 5 days (pcs.) | 61.21 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 62.04 EUR (3) |
Ø price 100 days | Ø volume 100 days (pcs.) | 66.36 EUR (8) |
Ø price 250 days | Ø volume 250 days (pcs.) | 72.36 EUR (4) |
YTD High | date | 88.34 EUR (2024/03/28) |
YTD Low | date | 54.39 EUR (2024/08/05) |
52 Weeks High | date | 88.34 EUR (2024/03/28) |
52 Weeks Low | date | 54.39 EUR (2024/08/05) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/11/08 | 17:35 | 61.72 EUR | 0.00 | 3 |
Vienna Stock Exchange | 2024/11/08 | 17:32 | 61.65 EUR | 0.00 | 5 |
Tradegate | 2024/11/08 | 22:26 | 61.80 EUR | 0.21 | 40 |
Stuttgart | 2024/11/08 | 21:31 | 61.96 EUR | 0.00 | 4 |
SIX Swiss Exchange | 2019/06/27 | 17:35 | 60.60 CHF | 0.00 | 1 |
NYSE | 2024/11/08 | 22:00 | 66.23 USD | 204.25 | 41,079 |
Munich | 2024/11/08 | 08:04 | 61.33 EUR | 0.00 | 2 |
London Stock Exchange | 2021/02/05 | 15:34 | 77.5596 CHF | 0.00 | 1 |
Frankfurt | 2024/11/08 | 08:20 | 60.77 EUR | 0.00 | 2 |
Euronext Milan MTF Trading After Hours | 2024/02/12 | 19:23 | 80.30 EUR | 0.01 | 1 |
Euronext Milan MTF Global Equity Market | 2024/11/08 | 17:44 | 61.65 EUR | 0.00 | 1 |
Duesseldorf | 2024/11/08 | 19:31 | 61.89 EUR | 0.00 | 7 |
Berlin | 2024/11/08 | 08:08 | 60.79 EUR | 0.00 | 2 |
EDWARDS LIFESCIENCES CORP. |
- - |
1 Edwards Way - 92614 Irvine |
Telefon: +1-949-250-2500 |
Fax: + |
E-mail: customerservice_us@edwards.com |
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA. |
Nicholas Valeriani | Chairman of Board of Directors |
David Feinberg | Member of Board of Directors |
Kieran Gallahue | Member of Board of Directors |
Leslie Davis | Member of Board of Directors |
Leslie Heisz | Member of Board of Directors |
Paul LaViolette | Member of Board of Directors |
Ramona Sequeira | Member of Board of Directors |
Steven Loranger | Member of Board of Directors |
Arnold A. Pinkston | Member of Executive Committee |
Bernard J. Zovighian | Member of Executive Committee |
Catherine M. Szyman | Member of Executive Committee |
Christine Z. McCauley | Member of Executive Committee |
Daveen Chopra | Member of Executive Committee |
Dirksen J. Lehman | Member of Executive Committee |
Donald E. Bobo, Jr. | Member of Executive Committee |
Gary I. Sorsher | Member of Executive Committee |
Jean-Luc Lemercier | Member of Executive Committee |
Joseph Nuzzolese | Member of Executive Committee |
Larry L. Wood | Member of Executive Committee |
Scott B. Ullem | Member of Executive Committee |
Todd J. Brinton | Member of Executive Committee |
Wayne Markowitz | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer